Novo Nordisk Type 2 Diabetes Drug Increases Weight Loss

Novo Nordisk's diabetes drug Victoza appears to be an effective weight loss therapy, according to data from a late-stage clinical trial. In a 56-week study of 846 overweight or obese adults with type 2 diabetes, a daily injection of 3 milligrams of Victoza led to significantly greater weight loss than did a placebo. Read the full story

More News:

All news »

What are your comments?

Join the discussion today. Login Here.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments